IHE

iShares U.S. Pharmaceuticals ETF [IHE] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

IHE Stock Summary

Top 10 Correlated ETFs

IHE

Top 10 Correlated Stocks

IHE

In the News

IHE Financial details

Company Rating
-
Market Cap
642.87M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.64
Dividend %
1.34%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-3.17%
SMA50
5.36%
SMA100
-0.37%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
55.363335-69.56
52W High
-0.64%
52W Low
+24.65%
RSI
38.51
Rel Volume
1.97
Avg Volume
72.67K
Volume
143.37K
Perf Week
-2.41%
Perf Month
-3.3%
Perf Quarter
-1.86%
Perf Half Y
-2.17%
-
-
-
-
Beta
0.57
-
-
Volatility
0.87%, 1.32%
Prev Close
-0.32%
Price
68.56
Change
-0.25%

IHE Financial Performance

IHE Dividend History

IHE Frequently Asked Questions

What is iShares U.S. Pharmaceuticals ETF stock symbol ?

iShares U.S. Pharmaceuticals ETF is a US stock and trading under the symbol IHE

What is iShares U.S. Pharmaceuticals ETF stock quote today ?

iShares U.S. Pharmaceuticals ETF stock price is $68.56 today.

Is iShares U.S. Pharmaceuticals ETF stock public?

Yes, iShares U.S. Pharmaceuticals ETF is a publicly traded company.

Something similar

Top by Market Cap
M&M.NS
VOO
GOOG
NVD.DE
AVGO
Top Correlated ETFs
IYH
CURE
FHLC
XHC.TO
VHT
Top Correlated Stocks
NVO
SHSCX
SHSKX
SHSSX
SHISX
Similar Market Cap
MOVI3.SA
BFST
CMAAX
ICVX
AME6.DE

Company Profile

Financial Services Asset Management
  • Volume Average 72.67K
  • Market Capitalization 642.87M
  • Headquarters US
  • IPO Date 2006-05-05

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.